Septerna, Inc. Reports Third Quarter GAAP EPS of -$0.57 and Revenue of $18.88M
Septerna, Inc. (SEPN) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) of -$0.57. The biotechnology company also disclosed quarterly revenue totaling $18.88 million. The report highlights the ongoing experimental nature of Septerna's GPCR (G protein-coupled receptor) programs. While current financials reflect typical early-stage biotech losses, market interest remains focused on the long-term potential of its drug development pipeline.
Tickers: $SEPN
Topics: earnings GAAP EPS revenue
Read the full article at Seeking Alpha
Part of the story Septerna, Inc. Reports Third Quarter GAAP EPS of -$0.57 and Revenue of $18.88M (3 articles)